In the House of Lords last week, a quiet but consequential exchange took place — one that exposed a regulatory anachronism sitting at the intersection of tax law, pension administration, and modern medicine. Treasury minister Lord Livermore confirmed that the Government intends to review the rules governing early pension access for the terminally ill, acknowledging that the current framework is, in his own words, “clearly outdated.”
The issue is straightforward, even if the regulatory tangle behind it is not. Under present rules, a person diagnosed with a terminal illness may access a Serious Ill Health Lump Sum from their private pension — but only if their life expectancy is less than twelve months. The sum can be taken tax-free for those under 75, up to a ceiling of £1.073 million, with any excess taxed as income. The problem is that medicine has moved on considerably since those thresholds were designed.
A Framework Built for a Different Era
The exchange was prompted by Labour peer Baroness Martin of Brockley — formerly Rachel Reeves’ chief of staff — who pressed the minister on whether the Government would update current practices. Her argument was grounded in clinical reality. For cancer patients alone, she noted, around half now survive ten years or more following diagnosis, compared with just one in four in the 1970s. A rule calibrated to a twelve-month prognosis therefore excludes a substantial and growing cohort of people who carry a terminal diagnosis but may live for a decade or longer.
This is not a fringe concern. It reflects a structural mismatch between regulatory design and medical progress — precisely the kind of institutional lag that erodes public confidence in the competence of government administration.
Lord Livermore did not demur. He told the chamber that the current definition “does not align with wider legislation, including the Department for Work and Pensions standard definition,” and confirmed that a review would now take place. He went further, indicating that the Government would examine access options across individual private pension schemes — each of which currently operates its own requirements — and consider what standardisation might be appropriate.
The Case for a Single Definition
That last point deserves emphasis. One of the more dysfunctional features of the current landscape is its fragmentation. Different pension schemes apply different criteria, meaning that two people with identical diagnoses may face entirely different hurdles depending on which provider administers their savings. This inconsistency is difficult to justify on either fairness or efficiency grounds.
Lord Livermore signalled a preference for harmonisation. “Although I can’t prejudge it,” he said, “it would be ideal if there was now one standard definition.” Aligning the pensions definition with the DWP’s existing standard would be a sensible starting point — administratively cleaner, and less prone to the arbitrary variation that currently disadvantages the most vulnerable claimants.
The stakes, for those affected, are not abstract.
A person diagnosed with a condition that is terminal but slow-moving — certain cancers, motor neurone disease, progressive neurological conditions — may have pressing financial needs that their pension savings could address, yet find themselves locked out by a rule written in an era when such diagnoses meant death within months. The funds are theirs. The barrier is a definitional artefact.
Balancing Access Against Long-Term Security
There is, of course, a legitimate counterweight to consider, and Lord Livermore acknowledged it directly. Any liberalisation of access rules must guard against the risk of financial hardship later in life — the scenario in which a person accesses their pension early, survives longer than anticipated, and is left without adequate retirement income. This is not a hypothetical concern; it is a genuine actuarial and welfare risk that any revised framework must take seriously.
The Government’s stated intention to examine safeguards alongside access options suggests it understands this tension. Getting the balance right will require careful design — not a blanket extension of eligibility, but a recalibration that reflects the clinical realities of modern terminal diagnoses while preserving the protective function that pension savings are meant to serve.
What is clear is that the status quo is no longer defensible. A regulatory definition rooted in the medical assumptions of a previous generation, applied inconsistently across hundreds of private schemes, and misaligned with the Government’s own departmental standards, is overdue for reform. The review Lord Livermore has confirmed is a necessary first step. The quality of what follows it will be the real test.